Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-FR Version v10-FR
Language French French
Date Updated 2022-01-12 2017-08-28
Drug Identification Number 02382814 02382814
Brand name TOBRAMYCIN INJECTION, USP TOBRAMYCIN INJECTION, USP
Common or Proper name TOBRAMYCIN INJECTION, USP TOBRAMYCIN INJECTION, USP
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients TOBRAMYCIN TOBRAMYCIN
Strength(s) 40MG 40MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 2ML 10VL 2ML 10VL
ATC code J01GB J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-05-01 2017-05-01
Estimated end date Unknown Unknown
Actual end date 2022-01-06
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Discontinued in shortage ID 152485. Last lot 7007753 Expiry October-31-2016.
Health Canada comments